Clinical Trial Update: Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on tofacitinib for axial spondyloarthritis (NSAID-refractory) across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• Tofacitinib (tofacitinib)

Snippet

Sponsor: Globe Pharmaceuticals Limited | Conditions: Axial Spondyloarthritis | Phase 2, Phase 3 | Status: UNKNOWN